Error: Could not add to watchlist. X

Challenger Global Fonds - Challenger Global Four Fonds

+ Watchlist
CHAGLFO:LX
11.87
EUR
0.07
0.59%
As of 00:59:30 ET on 07/03/2015.
Volume
0
Previous Close
11.94
52Wk Range
8.91 - 12.36
1 Yr Return
17.29%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/03/2015)
11.87
Total Assets (m EUR) (on 07/03/2015)
3.192
Inception Date
12/04/2002
Last Dividend (on 12/31/2012)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.35%
Expense Ratio
3.15%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 1.88 k 194.96 k 5.45
Eurofins Scientific SE 680.00 193.43 k 5.40
DexCom Inc 2.75 k 179.17 k 5.00
Constellation Software Inc/Can 470.00 178.29 k 4.98
Jazz Pharmaceuticals PLC 1.08 k 177.64 k 4.96
Allergan plc 620.00 177.45 k 4.96
Celgene Corp 1.62 k 170.20 k 4.75
MasterCard Inc 2.00 k 169.70 k 4.74
Coloplast A/S 2.40 k 165.54 k 4.62
Constellation Brands Inc 1.49 k 162.13 k 4.53
Profile
Challenger Global Four Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is capital appreciation. The Fund invests primarily in equities and equity-related securities issued in OECD member countries. The Fund may also invest in securities issued in emerging markets worldwide with the exception of Eastern Europe.
ADDRESS
Warburg Invest Luxembourg
2, place Francois-Joseph Dargent
L-1413 Luxembourg
Luxembourg
PHONE
352-42-44-911